(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
Compound with spectra: 1 NMR
![(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE](/api/compound/5Cbnay8dzfR.png?ph=true&h=300&w=458 "(1S,2R)-1-(4-METHYLPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE")
| SpectraBase Compound ID | 5Cbnay8dzfR |
|---|---|
| InChI | InChI=1S/C18H26N4O/c1-5-16(20-21-19)15-12-18(15,17(23)22(6-2)7-3)14-10-8-13(4)9-11-14/h8-11,15-16H,5-7,12H2,1-4H3/t15-,16-,18+/m0/s1 |
| InChIKey | ZKMKAQCDFMXSCK-XYJFISCASA-N |
| Mol Weight | 314.43 g/mol |
| Molecular Formula | C18H26N4O |
| Exact Mass | 314.210661 g/mol |
| Enantiomer InChIKey | ZKMKAQCDFMXSCK-NUJGCVRESA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S,2R)-1-(4-FLUOROPHENYL)-2-[(S)-1-AZIDOPROPYL]-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
(1S,2R)-1-PHENYL-2-[(S)-1-AZIDOPROPYL]-N,N-DIPROPYLCYCLOPROPANECARBOXAMIDE
1-[3-(4,4-DIPHENYL-1-ISOPROPYL-5-OXO-3-PYRROLIDINYL)PROPIONYL]HEXAMETHYLENEIMINE
tert-butyl (1S,5R)-1-(4-chlorophenyl)-2-oxo-3-azabicyclo[3.1.0]hexane-3-carboxylate
4,4-diphenyl-1-isopropyl-5-oxo-3-pyrrolidinepropionic acid, ethyl ester
N,N-dimethyl-4,4-diphenyl-1-isopropyl-5-oxo-3-pyrrolidinepropionamide
N-BUTYL-4,4-DIPHENYL-5-OXO-3-PYRROLIDINEPROPIONAMIDE
1-[3-(4,4-diphenyl-1-isopropyl-5-oxo-3-pyrrolidinyl)proionyl]pyrrolidine
(1S,2R)-1-(2-NAPHTHYL)-2-(HYDROXYMETHYL)-N,N-DIETHYLCYCLOPROPANECARBOXAMIDE
4,4-DIPHENYL-1-ISOPROPYL-N-METHYL-5-OXO-3-PYRROLIDINEPROPIONAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity | Bioorganic & Medicinal Chemistry | 2002 |